Prognostic value of Ki-67 immunolabelling in primary operable breast cancer
Open Access
- 1 September 1993
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 68 (3), 579-583
- https://doi.org/10.1038/bjc.1993.389
Abstract
The prognostic value of Ki-67 immunohistochemical labelling was evaluated in 327 operable primary carcinomas of the breast. The follow-up time was up to 4 years (mean 2.7 years). The disease-free survival in Ki-67 positive patients was shorter than in Ki-67 negative patients (P < 0.005). By combining the Ki-67 expression with ER receptors and stage, subgroups with a different disease-free survival were identified. In stage II patients there was a significant difference (P < 0.005) in disease-free survival between Ki-67 positive/ER negative and Ki-67 negative/ER positive patients. In node negative patients there was no such difference. The disease-free survival according to different prognostic factors, stage, ER and node status, were separately examined using a Cox's proportional hazards model. ER (P < 0.0001), the Ki-67 (P < 0.02), tumour size (P < 0.0001) and nodal status (P < 0.006) were independent prognostic factors. We conclude that the potential value of Ki-67 labelling for prognostic evaluation of patients with breast carcinoma is good.Keywords
This publication has 17 references indexed in Scilit:
- P53 and Ki‐67 Immunoreactivity in Human Prostate Cancer and Benign HyperplasiaBritish Journal of Urology, 1992
- Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancersEuropean Journal of Cancer and Clinical Oncology, 1991
- Epidermal growth factor receptor expression as a prognostic indicator in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67Breast Cancer Research and Treatment, 1991
- Assessment of proliferative activity in carcinomas of the human alimentary tract by Ki‐67 immunostainingInternational Journal of Cancer, 1991
- Evaluation of the prognostic value of triple node biopsy in early breast cancerBritish Journal of Surgery, 1990
- Amplification of c- erb B-2 and Aggressive Human Breast Tumors?Science, 1988
- Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variablesThe Journal of Pathology, 1987
- Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983